Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Roche acquires MS program and GvHD therapy receives Orphan Drug Designation

This week: Cynata's CYP-001 receives Orphan Drug Designation and Phase III disc degeneration trial completes enrollment.

Go to the profile of RegMedNet
Apr 05, 2018

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.


No comments yet.